Aldeyra Therapeutics
ALDX
#10236
Rank
โ‚น4.69 B
Marketcap
โ‚น77.84
Share price
16.39%
Change (1 day)
-82.48%
Change (1 year)

Earnings for Aldeyra Therapeutics (ALDX)

Earnings in 2026 (TTM): -โ‚น1.98 Billion

According to Aldeyra Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น2.97 Billion, an increase over its 2024 earnings that were of -โ‚น5 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aldeyra Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น1.98 Billion-33.3%
2025 -โ‚น2.97 Billion-40.77%
2024 -โ‚น5 Billion52.03%
2023 -โ‚น3.29 Billion-41.21%
2022 -โ‚น5.6 Billion7.67%
2021 -โ‚น5.2 Billion55.1%
2020 -โ‚น3.35 Billion-41.29%
2019 -โ‚น5.71 Billion58.81%
2018 -โ‚น3.6 Billion74.32%
2017 -โ‚น2.06 Billion19.56%
2016 -โ‚น1.73 Billion55.21%
2015 -โ‚น1.11 Billion142.32%
2014 -โ‚น0.46 Billion-137.39%
2013 โ‚น1.22 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
โ‚น526.99 B-26,387.74%๐Ÿ‡บ๐Ÿ‡ธ USA